| 107853435 |
107853458 |
4 |
- |
25494202 |
A375 |
resistance to PLX-4720 (puromycin) |
GAGGGAGAAAAGGAGTGGGGAGG |
SGMS2 |
ENSG00000164023 |
1.2710214141578144 |
[1,3] |
[0,1] |
5 |
dCas9-VP64 |
positive selection |
2397185 |
107844259 |
107844282 |
4 |
+ |
25494202 |
A375 |
resistance to PLX-4720 (puromycin) |
GGTTGCAGTGAGCTGAGATTGGG |
SGMS2 |
ENSG00000164023 |
0.09247990967442199 |
[398,266] |
[75,78] |
0 |
dCas9-VP64 |
positive selection |
2414651 |
107853435 |
107853458 |
4 |
- |
25494202 |
A375 |
resistance to PLX-4720 (zeocin) |
GAGGGAGAAAAGGAGTGGGGAGG |
SGMS2 |
ENSG00000164023 |
0.31978730936927524 |
[307,29] |
[95,44] |
2 |
dCas9-VP64 |
positive selection |
2492440 |
107844259 |
107844282 |
4 |
+ |
25494202 |
A375 |
resistance to PLX-4720 (zeocin) |
GGTTGCAGTGAGCTGAGATTGGG |
SGMS2 |
ENSG00000164023 |
-0.8679421240235777 |
[178,269] |
[31,46] |
-7 |
dCas9-VP64 |
positive selection |
2509906 |
107824939 |
107824962 |
4 |
+ |
27661255 |
K562 |
viability |
GCCGCGCCGTGGGCCGAGTGGGG |
SGMS2 |
ENSG00000164023 |
0.24981485342837795 |
[421,355] |
[402,342] |
8 |
dCas9-KRAB |
negative selection |
5510649 |
107824560 |
107824583 |
4 |
- |
27661255 |
K562 |
viability |
GCGGCAACAGAGATCAATCTGGG |
SGMS2 |
ENSG00000164023 |
0.04844497389038027 |
[302,278] |
[277,208] |
1 |
dCas9-KRAB |
negative selection |
5510650 |
107825012 |
107825035 |
4 |
- |
27661255 |
K562 |
viability |
GCCCCCGAGGCCGCACTCGGCGG |
SGMS2 |
ENSG00000164023 |
-0.2440956527803 |
[387,327] |
[286,203] |
-6 |
dCas9-KRAB |
negative selection |
5510651 |
107825015 |
107825038 |
4 |
- |
27661255 |
K562 |
viability |
GCCGCCCCCGAGGCCGCACTCGG |
SGMS2 |
ENSG00000164023 |
0.25436385128758465 |
[350,339] |
[357,304] |
8 |
dCas9-KRAB |
negative selection |
5510652 |